Updated: 07-Oct-26 09:09 ET
Co: TRXB
TRex Bio, Inc. (Nasdaq) | Clinical-stage biopharmaceutical company focused on tissue Treg biology for discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair | Initial Shares: 8.3 M | Initial Range: $14.00-$16.00 | Priced On: NA | Opened: NA | Underwriters: Lead: J.P.Morgan, Cantor/Evercore ISI, Stifel/, Wedbush PacGrow
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.
Co: SFPT
Safepoint Holdings (NYSE) | Provides specialty homeowners and commercial property insurance through managed reciprocal insurance exchanges and its own insurance carrier | Initial Shares: 16.7 M | Initial Range: $15.00-$17.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Deutsche Bank Securities, Morgan Stanley
Co: TKVA
Salspera (Nasdaq) | Biotech developing engineered bacteria-based immunotherapies that deliver anti-cancer signals directly into solid tumors | Initial Shares: 5.7 M | Initial Range: $14.00-$16.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Kingswood Capital Partners, LLC